Etopophos Preservative Free en es it fr

Etopophos Preservative Free Brand names, Etopophos Preservative Free Analogs

Etopophos Preservative Free Brand Names Mixture

  • No information avaliable

Etopophos Preservative Free Chemical_Formula

C29H32O13

Etopophos Preservative Free RX_link

http://www.rxlist.com/cgi/generic2/etopophos.htm

Etopophos Preservative Free fda sheet

http://www.accessdata.fda.gov/scripts/cder/onctools/labels.cfm?GN=etoposide,%20VP-16

Etopophos Preservative Free msds (material safety sheet)

Etopophos_Preservative_Free MSDS

Etopophos Preservative Free Synthesis Reference

No information avaliable

Etopophos Preservative Free Molecular Weight

588.557 g/mol

Etopophos Preservative Free Melting Point

236-251 oC

Etopophos Preservative Free H2O Solubility

58.7 mg/L

Etopophos Preservative Free State

Solid

Etopophos Preservative Free LogP

1.197

Etopophos Preservative Free Dosage Forms

Solution; Capsule; Liquid

Etopophos Preservative Free Indication

For use in combination with other chemotherapeutic agents in the treatment of refractory testicular tumors and as first line treatment in patients with small cell lung cancer. Also used to treat other malignancies such as lymphoma, non-lymphocytic leukemia, and glioblastoma multiforme.

Etopophos Preservative Free Pharmacology

Etoposide is an antineoplastic agent and an epipodophyllotoxin (a semisynthetic derivative of the podophyllotoxins). It inhibits DNA topoisomerase II, thereby inhibiting DNA synthesis. Etoposide is cell cycle dependent and phase specific, affecting mainly the S and G2 phases. Two different dose-dependent responses are seen. At high concentrations (10 µg/mL or more), lysis of cells entering mitosis is observed. At low concentrations (0.3 to 10 µg/mL), cells are inhibited from entering prophase. It does not interfere with microtubular assembly. The predominant macromolecular effect of etoposide appears to be the induction of DNA strand breaks by an interaction with DNA-topoisomerase II or the formation of free radicals.

Etopophos Preservative Free Absorption

Absorbed well, time to peak plasma concentration is 1-1.5 hrs. Mean bioavailability is 50%.

Etopophos Preservative Free side effects and Toxicity

Side effects include alopecia, constipation, diarrhea, nausea and vomiting and secondary malignancies (leukemia).

Etopophos Preservative Free Patient Information

Patients are generally advised to call their doctor in case of fever, symptoms of infection or painful injection sites, as these may progress severely without adequate medical attention. It is advised to drink lots of fluids after treatment to prevent damage to the bladder and kidneys, typically 1.5 to 3.5 litres of water on the day of treatment and for several days after.

Etopophos Preservative Free Organisms Affected

Humans and other mammals